The Centers for Disease Control and Prevention today released updated guidelines for clinicians prescribing opioids to outpatients for short- or long-term pain, which replace guidelines released in 2016. 

“The science on pain care has advanced over the past six years,” said Debbie Dowell, M.D., chief clinical research officer for CDC’s Division of Overdose Prevention. “During this time, CDC has also learned more from people living with pain, their caregivers, and their clinicians. We’ve been able to improve and expand our recommendations by incorporating new data with a better understanding of people’s lived experiences and the challenges they face when managing pain and pain care.”

Related News Articles

Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
In this episode – part four of AHA’s five-part series on opioid stewardship – Marie Cleary-Fishman, AHA’s vice president of clinical quality, is joined once…
Headline
In part three of AHA’s five-part series on opioid stewardship, Marie Cleary-Fishman, AHA’s vice president of clinical quality, speaks with Holly Geyer, M.D.,…
Headline
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in…
#HealthCareInnovation Thursday Blog
How could I have been so unprepared? I held my 3-year-old’s hand tighter than a pediatrician would approve of as together we watched paramedics resuscitate…
Headline
The Food and Drug Administration seeks comments through June 21 on a potential change that would require outpatient settings to dispense opioid pain…